# Strategic Integration of Clinical & Scientific Expertise in Dementia Care Innovation: A Comprehensive Roadmap for \'Best Day Phone\'

## Executive Summary

The digital health landscape for dementia care is undergoing a profound structural transformation, shifting rapidly from a fragmented market of generalized consumer electronics toward a disciplined ecosystem of clinically validated, purpose-built interventions. For \'Best Day Phone\'---a voice-first, screenless device designed for rituals and connection---the strategic integration of clinical expertise is not merely a branding exercise but a fundamental requirement for product viability, risk mitigation, and commercial scalability. As the sector matures, the \"move fast and break things\" ethos of traditional tech startups is proving incompatible with the complex, regulated, and ethically sensitive environment of memory care.

This report provides an exhaustive analysis of the strategic rationale, expert archetypes, ecosystem mapping, and governance structures necessary to embed dementia expertise into the product development lifecycle. The analysis is grounded in the current regulatory environment, specifically the Centers for Medicare & Medicaid Services (CMS) Guiding an Improved Dementia Experience (GUIDE) Model, the emergence of value-based care in Medicare Advantage, and the rigorous ethical standards demanded by the AgeTech sector.

Our research indicates that while \'Best Day Phone\' operates adjacent to regulated medical devices, its adoption in high-value channels---such as Memory Care communities, PACE (Program of All-Inclusive Care for the Elderly), and home health agencies---hinges on its ability to demonstrate \"clinical validity\" if not \"clinical efficacy.\" The \"Best Day Phone\" value proposition aligns with the theoretical framework of the \"Environmental Press Model,\" suggesting that simplifying the interface (screenless, voice-first) reduces the competence demand on the user, thereby maximizing function. However, realizing this potential requires precise calibration of the Voice User Interface (VUI) and ritual design, tasks that necessitate the involvement of Speech-Language Pathologists (SLPs), Occupational Therapists (OTs), and Geriatric Psychiatrists.

The report identifies a critical risk of \"tokenism\" in advisory boards and proposes a structured \"Co-Design and Clinical Validation\" model. It maps the ecosystem of potential partners, ranging from National Institute on Aging (NIA) funded research centers to operational leaders in senior living who face acute staffing shortages and are desperate for technology that reduces, rather than adds to, the caregiver burden. The following analysis offers a roadmap to navigate the intersection of commercial ambition and clinical integrity, ensuring that \'Best Day Phone\' not only enters the market but defines a new category of \"Ritual-Based Audio Interventions.\"

## Part 1: Strategic Rationale for Clinical Advisory Integration

The decision to integrate a clinical advisory board (CAB) or scientific advisory board (SAB) into the development of \'Best Day Phone\' serves five distinct strategic pillars: Credibility and Category Ownership, Design Integrity and Efficacy, Risk Mitigation, Reimbursement and Payer Alignment, and Commercial Velocity. Each of these pillars represents a critical failure point for past innovations in the space, and expert integration offers the primary mitigation strategy.

### 1.1 Credibility and Category Ownership in a Skeptical Market

The market for \"brain training\" and dementia-related technology is historically fraught with skepticism, largely due to a legacy of over-promised benefits and under-delivered results. The Federal Trade Commission\'s (FTC) landmark settlement against Lumosity, which resulted in a \$2 million fine for deceptive advertising regarding cognitive decline and dementia prevention, stands as a stark warning to new entrants.^1^ In this environment, consumer trust is low, and the burden of proof is high.

Establishing a formal relationship with recognized experts signals to the market---families, clinicians, and facility buyers---that the product is grounded in evidence-based principles rather than marketing hyperbole. As evidenced by HealthTrust's sourcing process, clinical advisory boards are integral to validating products before they enter the supply chain of major health systems.^2^ For \'Best Day Phone\', having a recognized neurologist or geriatric psychiatrist on the board provides the \"credential transfer\" necessary to move from a direct-to-consumer gadget to a trusted care tool recommended by discharge planners and social workers. This is not just about a logo on a website; it is about the \"trust halo\" that allows a social worker to recommend the device to a family in crisis without fearing professional reputational damage.

Furthermore, category ownership requires defining the standards of care. \'Best Day Phone\' aims to own the category of \"Ritual-Based Audio Interventions.\" To do this, it must publish or sponsor white papers and pilot studies that define *why* audio rituals matter. Experts provide the authorship and authority to validate this new category, distinguishing it from mere communication devices. For instance, companies like Altoida have successfully utilized advisory boards comprising leaders in AI and pharma to position themselves as \"category-defining\" platforms in precision neurology.^3^ By mirroring this approach, \'Best Day Phone\' can elevate its market position from a \"device\" to a \"therapeutic adjunct.\"

### 1.2 Design Integrity: The Environmental Press Model and Theoretical Alignment

The core value proposition of \'Best Day Phone\'---screenless and voice-first---aligns perfectly with Lawton's **Competence and Environmental Press Model**. This theoretical framework, a cornerstone of environmental gerontology, posits that behavior is a function of the competence of the individual and the \"press\" (demand) of the environment.^4^ As individual competence declines due to dementia (affecting biological, sensory, and cognitive domains), the environment must become less demanding to maintain adaptive behavior and affect.^5^

#### The Mismatch Risk and the \"Engineer\'s Fallacy\"

General consumer technology often increases environmental press through complex menus, visual clutter, abstract workflows, and demanding update cycles. This mismatch pushes the user with dementia into a state of maladaptive behavior, anxiety, or apathy.^6^ This is the \"Engineer\'s Fallacy\"---building what is technically possible rather than what is clinically necessary. Without clinical input, product teams often overestimate the user\'s ability to learn new procedural tasks, leading to immediate device abandonment---a common failure mode in AgeTech.^8^

#### The Role of Functional Experts

Occupational Therapists (OTs) and Speech-Language Pathologists (SLPs) are the practical experts in manipulating environmental press. An OT can validate whether the physical interaction of the phone minimizes motor demand, ensuring that the \"press\" of the device does not exceed the user\'s \"competence\".^9^ Meanwhile, an SLP is essential for guiding the Voice User Interface (VUI) design. Dementia affects language processing in specific ways, including anomia (word-finding difficulties) and delayed processing speeds. An SLP can ensure the device utilizes \"right-branching sentences\" (Subject-Verb-Object) and allows for extended listening windows, accommodating the user\'s cognitive deficits.^11^ This expertise transforms the device from a frustration trigger into a supportive prosthetic for communication.

### 1.3 Risk Mitigation: Ethical, Privacy, and Regulatory Compliance

Operating in the dementia space introduces profound ethical and regulatory risks. The user base is vulnerable, often lacking the capacity for informed consent, and the regulatory environment is becoming increasingly stringent regarding digital health technologies (DHTs).

#### Privacy, Surveillance, and the \"Panopticon\" Effect

Voice-first devices are inherently surveillance tools. There is a high sensitivity regarding \"eavesdropping\" in private homes and, increasingly, in care facilities where dignity is paramount. The concept of \"privacy\" for people with dementia is often overlooked, with researchers noting that privacy is frequently violated in care settings.^13^ An ethics-focused advisor can help navigate the \"privacy vs. safety\" trade-off, ensuring the product incorporates \"Privacy by Design\" principles such as hardware mute switches, transparent data policies, and \"assent\" protocols for users who cannot legally consent.^14^ This protects the company from the reputational damage associated with data scandals, such as the recent data breaches in senior living facilities.^16^

#### Unintended Consequences and Neuropsychiatric Risks

Poorly designed voice interactions can cause distress. For example, a voice assistant that doesn\'t understand a user might trigger agitation or feelings of incompetence. More critically, hallucinations and delusions are common in Lewy Body and Alzheimer\'s dementia; a disembodied voice could inadvertently feed a delusion if not carefully designed.^17^ Clinical experts, particularly Geriatric Psychiatrists, are essential to foresee and mitigate these neuropsychiatric risks. They can advise on \"safety rails\" for the AI, ensuring that the device does not hallucinate or provide harmful advice, a risk identified by the FDA\'s Digital Health Advisory Committee regarding generative AI in mental health.^19^

#### Regulatory Drift and FDA Oversight

While \'Best Day Phone\' is not a medical device *today*, the FDA is increasingly scrutinizing digital health tools. The newly formed FDA Digital Health Advisory Committee (DHAC) is actively discussing the regulation of AI-enabled devices, particularly those that interact with mental health populations.^21^ An advisory board monitors this regulatory horizon, ensuring that marketing claims do not inadvertently cross the line into \"diagnosis\" or \"treatment,\" which would trigger expensive 510(k) requirements. This proactive compliance strategy is vital for long-term viability.

### 1.4 Commercial Alignment: Medicare and Value-Based Care

The U.S. healthcare payment landscape is shifting decisively toward value-based care, where providers are paid for outcomes---specifically, keeping patients healthy at home and avoiding hospitalizations---rather than fee-for-service. This shift creates a massive commercial opportunity for technologies that can demonstrate alignment with these goals.

#### The CMS GUIDE Model

The new \"Guiding an Improved Dementia Experience\" (GUIDE) Model is a voluntary, nationwide model testing the impact of comprehensive dementia care management.^23^ GUIDE incentivizes caregiver support, education, and *respite services*.^24^ If \'Best Day Phone\' can demonstrate that it provides \"micro-respite\" for caregivers (by keeping the person with dementia engaged and safe), it could potentially be reimbursed or subsidized by GUIDE participants as a caregiver support tool. This aligns the product directly with the financial incentives of the 390 organizations currently participating in the model.^23^

#### PACE Programs and Cost Avoidance

Programs of All-Inclusive Care for the Elderly (PACE) are fully capitated payers responsible for the total cost of care for their enrollees. They are highly motivated to adopt technologies that prevent costly adverse events like wandering, agitation, or falls.^25^ PACE enrollees often have high levels of impairment, making them ideal candidates for a simplified, screenless device. An advisory board with experience in PACE or managed care can guide the collection of \"pharmacoeconomic\" data needed to sell into these networks---proving, for example, that the device reduces the need for PRN psychotropic medications.

#### Clinical Validation as a Sales Enabler

To sell into GUIDE participants, PACE programs, or large Memory Care chains, \'Best Day Phone\' needs data. It does not necessarily need a randomized controlled trial (RCT) published in *JAMA*, but it does need \"clinical validation\" pilots. An SAB can design these pilot studies to prove that the device reduces agitation or improves caregiver sleep---metrics that matter to payers.^27^ This transforms the sales pitch from \"it\'s a nice gadget\" to \"it\'s an evidence-based intervention.\"

## Part 2: Expert Archetypes and Comparative Analysis

To build an effective advisory ecosystem, it is crucial to distinguish between different types of experts. A \"Dementia Expert\" is not a monolith; a neurologist offers a completely different value proposition than a memory care facility director. We define four primary archetypes relevant to \'Best Day Phone\'.

### 2.1 The Clinician: Neurologist / Geriatric Psychiatrist

- **Focus:** The medical pathology of the brain, disease progression, pharmacological management, and neuropsychiatric symptoms (agitation, depression, delusions).

- **Expertise in Context:** These experts understand the biological \"hardware\" failure of dementia. They deal with the consequences of the disease, including behavioral disturbances that often lead to institutionalization.

- **Value to Product:**

  - **Credibility:** High. \"Designed with Neurologists\" carries significant weight with consumers and investors, as seen with companies like Altoida.^3^

  - **Risk Management:** Essential for understanding behavioral triggers. They can advise on how the device should respond if a user expresses distress, paranoia, or suicidal ideation.^19^

  - **Clinical Trials:** Necessary if the company ever pursues FDA clearance or formal clinical efficacy claims.

- **Limitations:** They often have little visibility into the *daily* lived reality of the home environment. They see patients in 15-minute clinical windows, not during the \"sundowning\" period at 5:00 PM when the device is most needed.

- **Key Profile:** A **Geriatric Psychiatrist** is often more valuable for this specific product than a general Neurologist. While neurologists focus on diagnosis, geriatric psychiatrists focus on *management* of behavior and mood---the exact domains \'Best Day Phone\' targets.^29^

### 2.2 The Functional Expert: Occupational Therapist (OT) / Speech-Language Pathologist (SLP)

- **Focus:** Activities of Daily Living (ADLs), functional communication, environmental modification, and compensatory strategies.

- **Expertise in Context:** These are the \"engineers of daily life.\" They understand how to modify a task or environment to match the patient\'s remaining abilities.

- **Value to Product:**

  - **UX/UI Design:** The most critical archetype for the *actual design* of the device.

  - **SLP:** Experts in aphasia, anomia, and processing delays. They can script the voice assistant\'s prompts to match the cognitive speed of the user (e.g., avoiding open-ended questions like \"What do you want to do?\" in favor of forced-choice \"Do you want music or a story?\").^11^ They understand that voice interactions must be forgiving of pauses and dysarthria, preventing the frustration that leads to abandonment.^30^

  - **OT:** Experts in physical interaction and routine. They can advise on the device\'s form factor (tactile buttons, visibility) and how to integrate the phone into daily rituals (the \"habit loop\") to support aging in place.^10^

- **Limitations:** Lower public profile than MDs; less helpful for high-level corporate fundraising but indispensable for product-market fit.

- **Key Profile:** An SLP specializing in Primary Progressive Aphasia (PPA) or dementia communication strategies, often found in academic medical centers or specialized private practice.^32^

### 2.3 The Researcher: Academic / PhD Scientist

- **Focus:** Efficacy studies, grant funding (SBIR/NIA), theoretical frameworks (Environmental Press, Person-Centered Care), and peer-reviewed publication.

- **Expertise in Context:** They live in the world of data, p-values, and rigorous methodology. They are the gatekeepers to the scientific community.

- **Value to Product:**

  - **Evidence Generation:** Designing the pilot studies to prove the device works. This evidence is the currency needed for partnerships with insurers or large health systems.^33^

  - **Grant Access:** Can serve as a Principal Investigator (PI) on non-dilutive funding applications (e.g., NIH SBIR grants for AgeTech).^35^

  - **Data Integrity:** Ensuring data collected by the device is valid for research purposes (digital biomarkers), potentially opening a secondary revenue stream.^37^

- **Limitations:** Can be slow-moving; academic timelines often conflict with startup \"sprint\" cycles. May focus too much on theoretical perfection over shipping a product.

- **Key Profile:** A researcher with a track record in \"psychosocial interventions\" or \"non-pharmacological approaches\" to dementia.^38^

### 2.4 The Operator: Memory Care Director / Home Care Administrator

- **Focus:** Staffing efficiency, workflow, resident safety, family satisfaction, and the \"bottom line\" of care delivery.

- **Expertise in Context:** They face the \"staffing crisis\" daily. They know exactly why technology fails in their buildings (e.g., Wi-Fi issues, lost chargers, staff refusal to use complex tools).^40^

- **Value to Product:**

  - **Implementation:** They provide the \"reality check.\" If the device requires a staff member to spend 5 minutes setting it up every day, it will fail.

  - **Buyer Persona:** They represent the B2B buyer. They can tell you if the price point works and if the device solves a staffing problem (e.g., \"Can this device distract a resident while I bathe another?\").^42^

  - **Real-World Testing:** Gatekeepers to pilot sites and \"living labs.\"

- **Limitations:** Focused on operational utility, not clinical theory. They prioritize \"does it stop the resident from pressing the call bell?\" over \"does it improve cognition?\"

- **Key Profile:** A Regional Director of Memory Care or Innovation at a large operator (e.g., Arrow Senior Living, Silverado) who has a demonstrated track record of piloting new technologies.^43^

#### Table 1: Comparative Fit Analysis of Expert Archetypes

  --------------------------------------------------------------------------------------------------------------------------------------
  **Expert Type**                **Credibility / PR**   **UX / Design**   **Clinical Risk**   **Commercial / B2B**   **Cost / Equity**
  ------------------------------ ---------------------- ----------------- ------------------- ---------------------- -------------------
  **Neurologist / Geri-Psych**   **High**               Low               **High**            Medium                 High

  **OT / SLP**                   Medium                 **High**          Medium              Low                    Medium

  **Academic Researcher**        Medium                 Medium            Medium              Low                    Low (Grants)

  **Operator / Director**        Low                    Medium            Low                 **High**               Medium
  --------------------------------------------------------------------------------------------------------------------------------------

**Strategic Recommendation:** \'Best Day Phone\' requires a **Composite Board** to cover these diverse bases.

1.  **Lead Clinician:** A Geriatric Psychiatrist (focus on behavior/mood).

2.  **Design Lead:** A Speech-Language Pathologist (focus on voice interaction).

3.  **Operational Lead:** A Memory Care Director (focus on implementation).

## Part 3: Search Strategy & Ecosystem Map

To identify the right experts, we must map the ecosystem of organizations leading the charge in dementia care, AgeTech, and research. This mapping reveals where the \"thought leaders\" congregate and where the funding flows.

### 3.1 Target Organizations & Ecosystem Map

#### A. Policy & Advocacy Giants (Credibility & Reach)

- **Alzheimer's Association:** This is the 800-pound gorilla of the space. The Technology and Dementia focus groups within their **International Society to Advance Alzheimer\'s Research and Treatment (ISTAART)** are prime hunting grounds for researchers who are also interested in tech.

- **AARP AgeTech Collaborative:** A massive hub for startups and advisors. Advisors here are already vetted for their interest in innovation and understanding of the \"longevity economy\".^44^

- **Dementia Care Aware:** A California-based initiative focusing on cognitive health assessment. This is an excellent source for finding primary care physicians who are on the front lines of early detection and care planning.^46^

#### B. Federal & Research Institutions (Funding & Evidence)

- **National Institute on Aging (NIA):** Specifically, the **Small Business Innovation Research (SBIR)** division. The NIA manages a \$150 million annual budget for small businesses developing aging interventions. Look for researchers who have successfully partnered with small businesses on \"Aging in Place\" technologies or \"Dementia Care\" grants.^35^ These individuals understand the dual pressures of science and commerce.

- **Alzheimer's Disease Research Centers (ADRCs):** There are approximately 37 NIA-funded ADRCs across the US. Each has a specific flavor:

  - *UC San Diego (Shiley-Marcos ADRC):* Strong focus on prevention, lifestyle interventions, and Latino health.^48^

  - *Brown University (Center for Alzheimer's Disease Research):* Leadership in \"bench to bedside\" translation and pragmatic clinical trials.^50^

  - *NYU Langone (Center for Cognitive Neurology):* A hub for psychosocial interventions and non-pharmacological research.^51^

  - *Emory University (Goizueta ADRC):* Strong community engagement and education focus, ideal for understanding the caregiver\'s perspective.^52^

#### C. Clinical & Care Delivery Leaders (The Market)

- **CMS GUIDE Model Participants:** A published list of \~390 organizations recently selected to pilot the new dementia care model. These are the most forward-thinking care providers in the US right now. Advisors from these orgs (e.g., *Alice Peck Day Memorial Hospital*, *Alivia Care Solutions*) understand the reimbursement landscape better than anyone else because they are actively shaping it.^23^

- **PACE Organizations:** Programs like *InnovAge* or local PACE centers. Their medical directors are incentivized to keep patients stable at home and avoid hospital admissions. They are pragmatic buyers of preventative tech.^25^

- **Memory Care Operators:** Chains like *Silverado*, *Belmont Village*, and *Arrow Senior Living*. Look for \"VP of Memory Care\" or \"Director of Innovation\" titles. These individuals are often the gatekeepers for pilot programs.^43^

#### D. Technology & Digital Health Innovation (Partnerships)

- **Digital Health Advisory Committee (FDA):** Members of this new committee are the foremost experts in the regulation of AI in healthcare. While they may be conflicted out of direct advisory roles, their public writings and presentations provide a roadmap for regulatory compliance.^21^

- **Competitor/Peer Advisory Boards:** Analyze the boards of successful AgeTech companies like *Altoida* ^3^, *Sensi.ai* ^55^, or *Neurotrack*.^56^ These companies have already identified high-value advisors; understanding who they work with can provide a shortlist of \"tech-friendly\" clinicians.

### 3.2 Individual Profile Types to Search For

**The \"Scholar-Entrepreneur\"**

- *Profile:* A PhD or MD who has spun out a company or served on an SBIR grant review panel. They understand that a \"perfect\" study is the enemy of a \"shipped\" product.

- *Keywords:* \"Translational research,\" \"Digital biomarker,\" \"Psychosocial intervention,\" \"NIA grant recipient.\"

- *Where to find:* University tech transfer offices, LinkedIn (cross-reference \"Professor\" + \"Advisor\").

**The \"Pragmatic Clinician\"**

- *Profile:* An SLP or OT who publishes on \"functional strategies\" or \"assistive technology.\" They are less concerned with the molecular biology of plaques and tangles and more concerned with whether a patient can make a phone call.

- *Keywords:* \"Augmentative and Alternative Communication (AAC),\" \"Dysarthria in dementia,\" \"Environmental press,\" \"Routine establishment.\"

- *Where to find:* American Speech-Language-Hearing Association (ASHA) special interest groups (SIG 2: Neurogenic Communication Disorders), American Occupational Therapy Association (AOTA).

**The \"Policy Insider\"**

- *Profile:* Former CMS officials or executives at advocacy groups who understand payment models. They can guide the company toward reimbursement codes (CPT) or value-based contracts.

- *Keywords:* \"Value-based care,\" \"GUIDE Model,\" \"CPT codes for remote monitoring,\" \"Caregiver support policy.\"

- *Where to find:* LinkedIn, speakers at the \"Aging in America\" conference.

## Part 4: Relationship Structure & Governance

Recruiting experts is only the first step. Structuring the relationship correctly is vital to ensure value, prevent \"tokenism,\" and manage costs. A poorly managed advisory board is a drain on resources and a source of frustration for both the company and the advisors.

### 4.1 Relationship Models

**1. The Scientific Advisory Board (SAB)**

- *Structure:* Formal body, meets quarterly.

- *Focus:* Long-term strategic validation, clinical trial design, publishing data, and regulatory strategy.

- *Members:* Neurologists, PhD Researchers, Policy Experts.

- *Deliverables:* White papers, study protocols, conference presentations, grant applications.

**2. The Clinical/Design Council (Working Group)**

- *Structure:* Informal, ad-hoc, meets monthly or \"on-demand.\"

- *Focus:* Product features, UX testing, script writing for the voice assistant, rapid iteration.

- *Members:* SLPs, OTs, Memory Care Directors.

- *Deliverables:* User flow critiques, VUI script reviews, pilot site access, \"heuristic evaluations\" of prototypes.

**3. The \"Name\" Advisor (Brand Ambassador)**

- *Structure:* Low touch, high visibility.

- *Focus:* Credibility, introductions to investors/customers, public relations.

- *Members:* Famous figures in the dementia space (e.g., the Teepa Snow archetype) or high-profile researchers.^55^

### 4.2 Compensation Benchmarks

Compensation varies significantly based on the stage of the startup (Seed vs. Series A) and the type of expert. It is critical to balance equity (long-term alignment) with cash (immediate value).^57^

**Equity vs. Cash Models:**

- **Standard Advisor (Early Stage):** Typically compensated in **Equity**.

  - *Grant Size:* 0.1% to 0.25% of the company (vested over 2 years).

  - *Expectation:* Quarterly meetings, occasional calls, name usage on deck.

  - *Note:* Benchmarks suggest 0.1-0.2% for standard members and slightly higher for the Chair.^59^

- **Working Advisor / Consultant:** Compensated in **Cash** or **Equity + Cash**.

  - *Rate:* \$150 - \$400 per hour for clinicians (MDs/PhDs).

  - *Retainer:* \$2,000 - \$5,000 per month for heavy involvement (e.g., leading a clinical study).

  - *Project Fee:* \$1,500 - \$3,000 per day for SAB meetings.^60^

- **Digital Health Norms:** Physicians typically expect FMV (Fair Market Value) for their time to comply with Stark Law/Anti-Kickback statutes if they are in a position to refer patients. Even for a non-medical device, adhering to FMV is a best practice to maintain ethical standing.^57^

### 4.3 Advisory Board Charter & Governance

To prevent the board from becoming a \"ghost town\" (names on a website who never meet), a Charter is essential. This document sets the rules of engagement.^61^

**Key Charter Elements:**

1.  **Mission Statement:** Explicitly link the board's work to the product mission (e.g., \"To ensure Best Day Phone adheres to clinical best practices for dementia care and promotes user dignity\").

2.  **Term Limits:** 12 to 24 months. This allows the company to cycle out experts as needs change (e.g., shifting focus from Design to Commercialization) without awkward conversations.^63^

3.  **Roles & Responsibilities:**

    - *Critique:* \"Brutal honesty\" on product roadmap is expected.

    - *Network:* Intro to 3 pilot sites or investigators per year.

    - *Content:* Review 2 blog posts or white papers per year.

4.  **Intellectual Property (IP):** Crucial clause. Any ideas generated during advisory sessions belong to the company. Advisors must assign IP rights to the startup.^63^

5.  **Conflict of Interest:** Advisors must disclose relationships with competitors or regulated entities. This is particularly important for academics who may have conflicting grant obligations.^63^

### 4.4 Preventing Tokenism via Co-Design

\"Tokenism\" occurs when experts are used solely for their logos. This backfires when products fail clinically because the expert never actually looked at the detailed design.

- **Meaningful Engagement:** Move beyond \"show and tell.\" Use **Co-Design Workshops**.^34^ Instead of asking \"Do you like this?\", assign specific problems: \"How should the device handle a user who repeats the same question 10 times in a minute?\"

- **The \"Proxy\" Model:** Since people with dementia cannot always participate in standard focus groups effectively (especially in later stages), the Advisors (especially OTs and Care Directors) act as high-fidelity proxies. However, the *best* practice is to include people with early-stage dementia in the process, facilitated by these experts, to ensure the \"voice of the lived experience\" is heard.^66^ This \"participatory design\" approach is the gold standard in modern dementia research.

## Part 5: Risks of Exclusion (The Cost of Doing It Alone)

Failing to integrate clinical experts introduces existential risks to the product, ranging from market rejection to regulatory enforcement.

### 5.1 Product Risks (The \"Paperweight\" Problem)

- **Abandonment:** The most common failure in AgeTech. If the VUI is not tuned to the processing speed of a dementia brain (which requires longer \"listening windows\" and simplified syntax), the user will fail to interact. The device becomes a paperweight, leading to churn and negative reviews.^67^

- **Agitation Triggers:** A voice that is too loud, too fast, or too \"robotic\" can trigger catastrophic reactions (agitation, fear) in patients with sensory processing sensitivity (Hyperacusis). Without an SLP/Audiologist review, the product may inadvertently cause harm rather than comfort.^18^

- **Incompatibility with Routine:** If the device requires charging or setup that disrupts the rigid routines of a Memory Care facility, staff will unplug it. An Operator advisor prevents this \"workflow mismatch\" by ensuring the device fits seamlessly into the facility\'s operational rhythm.^41^

### 5.2 Ethical & Privacy Risks

- **Surveillance & Consent:** Recording audio in the home of a person who lacks legal capacity is a legal and ethical minefield. Families worry about \"spying\" and data exploitation. An ethicist or geriatric psychiatrist can help frame the consent model (e.g., \"Assent\" vs. \"Consent\") and design features like \"hardware mute\" switches that are visible and understandable.^14^

- **Data Exploitation:** The AgeTech market is sensitive to data monetization. If \'Best Day Phone\' is perceived as harvesting data to sell to advertisers (similar to the concerns raised by the Life Care Services data breach or tech support scams targeting seniors), the brand will be toxic.^16^ A Governance Board provides a \"trust halo\" and ensures ethical data practices are followed.

### 5.3 Regulatory Risks

- **FTC Enforcement:** The FTC aggressively pursues companies making unsubstantiated cognitive health claims (e.g., \"Improves Memory,\" \"Delays Dementia\"). The Lumosity case (\$2M settlement) is the precedent that every digital health executive must know.^1^ An SAB ensures that marketing copy stays within the bounds of \"wellness\" and \"support\" rather than \"treatment,\" protecting the company from fines.

- **FDA \"Function Creep\":** As the device gets smarter (e.g., using AI to detect mood changes or cognitive decline), it risks becoming \"Software as a Medical Device\" (SaMD). The FDA Digital Health Advisory Committee is actively defining these lines.^21^ Without expert guidance, the product roadmap might inadvertently cross into Class II medical device territory, triggering expensive compliance requirements that the startup is not prepared to handle.

## Detailed Research & Analysis

### Section 1: The Design Challenge -- Voice-First for the Dementia Brain

The decision to make \'Best Day Phone\' screenless is strategically sound but technically perilous. The \"Environmental Press\" model suggests that removing screens removes visual clutter, which is beneficial.^5^ However, it places 100% of the interaction burden on the auditory channel.

The SLP Perspective (Why you need a Speech Pathologist):

Dementia affects language processing in specific ways:

1.  **Anomia:** Difficulty finding words. If the user can\'t remember the \"wake word\" or the specific command, a standard Alexa/Siri interface fails. An SLP advisor would recommend \"always-listening\" context-aware modes or extremely simple physical prompts to initiate voice.^30^

2.  **Processing Delay:** It takes longer to parse a sentence. Standard voice assistants have aggressive \"timeout\" windows. If the user pauses to think, the device cuts them off. This interruption can cause shame and frustration.^30^

3.  **Syntactic Complexity:** \"Right-branching sentences\" (Subject-Verb-Object) are easier to understand than complex clauses.^11^

4.  **Prosody & Tone:** The *emotional* content of the voice matters more than the words. A \"commanding\" tone can trigger resistance; a \"collaborative\" tone fosters cooperation.^12^

*Insight:* An SLP Advisor will not just \"review\" the product; they should write the *VUI Style Guide*. They will mandate \"errorless learning\" protocols where the device never tells the user they are \"wrong,\" but gently redirects them, preserving dignity.

### Section 2: The Operator\'s Reality -- Why Tech Fails in Memory Care

Memory Care Directors are overwhelmed. Staff turnover is high. They do not want another \"gadget\" that staff have to manage.

- **The \"Wi-Fi Problem\":** Enterprise Wi-Fi in senior living is notoriously restrictive (firewalls, login portals). Consumer devices often can\'t connect. An Operator Advisor would warn you: \"If it needs a captive portal login, it will fail.\" Cellular-first connectivity is often a requirement.^40^

- **The \"Charger Problem\":** Cords are trip hazards. Devices get lost in laundry.

- **The Value Prop:** Operators don\'t care about \"cool tech.\" They care about **\"The Witching Hour\" (Sundowning)**. If \'Best Day Phone\' can engage a resident at 4:00 PM when agitation peaks, allowing staff to focus on shift change or dining prep, it is a \"must-have\" product.

*Insight:* The Operator Advisor will help position the product as a \"Staff Multiplier\" rather than a \"Resident Toy.\"

### Section 3: The Reimbursement Pathway -- GUIDE & PACE

The CMS GUIDE Model is a game-changer. It pays for \"Caregiver Support and Education\" and \"Respite.\"

- **Strategic Opportunity:** If \'Best Day Phone\' provides *respite* to the caregiver (by keeping the person with dementia occupied and safe for 30 minutes), it aligns with GUIDE funding objectives.^23^

- **Data Requirement:** To unlock this, the company needs data. \"We reduced caregiver burden by X%.\" This is where the **Academic Researcher** is vital. They can design a pilot study using validated scales (e.g., Zarit Burden Interview) to prove this claim.

## Actionable Next Steps

### Phase 1: Foundation (Months 1-3)

1.  **Draft the Charter:** Create a simple 2-page document outlining roles, IP ownership, and the \"Mission of Dignity.\"

2.  **Recruit the \"Keystone\" Advisor:** Target a **Geriatric Psychiatrist** or a well-known **SLP Researcher**. Their name will attract others.

3.  **Hire a \"Fractional\" Memory Care Director:** Find a recently retired regional director to consult on the \"Operator\" reality.

### Phase 2: Design & Validation (Months 4-6)

1.  **VUI Audit:** Have the SLP advisor review every single voice prompt for \"dementia-friendliness\" (syntax, speed, tone).

2.  **Ethics Review:** Convene a session specifically on privacy and \"unintended consequences\" (e.g., what if the user thinks the person in the phone is real?).

3.  **Proxy Testing:** Run a co-design workshop with the advisors acting as proxies for the users to test the physical prototype.

### Phase 3: Evidence & Market (Months 7-12)

1.  **Pilot Study:** Launch a small pilot (N=50) in a partner Memory Care community, overseen by the Academic Advisor. Focus on \"Engagement Time\" and \"Agitation Reduction.\"

2.  **White Paper:** Publish the results, co-authored by the Board. Use this to approach CMS GUIDE participants.

3.  **Commercial Rollout:** Use the Board\'s credibility to secure distribution partnerships with Home Care agencies.

## Tables & Data

### Table 1: Compensation Benchmarks for Advisory Board Members

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Role**                          **Equity Grant (Vested 2 Yrs)**   **Cash Retainer (Optional)**   **Meeting Cadence**   **Key Deliverable**
  --------------------------------- --------------------------------- ------------------------------ --------------------- --------------------------------------------
  **Chairperson**                   0.25% - 0.50%                     \$5k - \$10k / yr              Monthly               Strategic alignment, recruitment of others

  **Clinical Advisor (MD)**         0.10% - 0.25%                     Hourly (\$200-\$400)           Quarterly             Risk review, clinical validity check

  **Functional Advisor (SLP/OT)**   0.10% - 0.20%                     Hourly / Project               Monthly               UX/VUI audit, feature design

  **Operator (Director)**           0.10% - 0.15%                     Free Product / Pilot           Bi-Monthly            Workflow fit, pilot site access
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------

### Table 2: Target Organization Profiles for Recruitment

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Organization Type**     **Example Orgs**                                              **Target Role**                                **Goal**
  ------------------------- ------------------------------------------------------------- ---------------------------------------------- -------------------------------------
  **Research Center**       UCSD Shiley-Marcos, NYU Langone, Brown University             Principal Investigator (PI), Post-Doc Fellow   Clinical credibility, SBIR grants

  **Advocacy / Policy**     Alzheimer\'s Association, Dementia Care Aware                 Program Director, Policy Analyst               Market access, regulatory foresight

  **Care Provider**         CMS GUIDE Participants (e.g., Alivia Care), InnovAge (PACE)   Chief Medical Officer, VP of Innovation        B2B Sales, reimbursement pilots

  **Professional Assoc.**   ASHA (Speech), AOTA (Occupational Therapy)                    Special Interest Group (SIG) Chair             Design validation, best practices
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### Table 3: Risk Matrix - The Cost of Exclusion

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Risk Category**   **Scenario**                                               **Consequence without Expert**                           **Mitigation via Board**
  ------------------- ---------------------------------------------------------- -------------------------------------------------------- --------------------------------------------------------------------------
  **Product**         User gets stuck in a loop or can\'t find the right word.   Device abandonment; increased caregiver frustration.     SLP designs \"errorless learning\" scripts & adaptive listening windows.

  **Ethical**         User becomes paranoid about the \"voice in the box.\"      Emotional harm; family backlash; brand damage.           Geri-Psych protocols for \"wind-down\" and reassurance.

  **Regulatory**      Marketing claims \"Helps Memory.\"                         FTC Investigation; fines (Lumosity precedent).           Board reviews all copy for compliance (Wellness vs. Medical).

  **Commercial**      Device requires complex Wi-Fi login.                       Returns from facilities; \"doesn\'t work\" reputation.   Operator advisor ensures \"out of box\" cellular connectivity.
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

## Conclusion

For \'Best Day Phone\', the integration of a Clinical Advisory Board is the bridge between a well-intentioned gadget and a transformative care solution. The dementia care ecosystem is complex, high-stakes, and increasingly regulated. By engaging the right mix of **Clinicians** (for safety), **Functional Experts** (for usability), and **Operators** (for viability), the company can de-risk its product roadmap and position itself as a leader in the emerging era of value-based AgeTech. The \"Environmental Press\" model provides the theoretical \"North Star,\" but only through the practical guidance of these experts can that theory be translated into a \"Best Day\" for the user. The path forward is clear: validate the science, respect the user, and operationalize the empathy that is at the heart of the product\'s mission.

#### Works cited

1.  Lumosity to Pay \$2 Million to Settle FTC Deceptive Advertising Charges for Its "Brain Training" Program, accessed December 15, 2025, [[https://www.ftc.gov/news-events/news/press-releases/2016/01/lumosity-pay-2-million-settle-ftc-deceptive-advertising-charges-its-brain-training-program]{.underline}](https://www.ftc.gov/news-events/news/press-releases/2016/01/lumosity-pay-2-million-settle-ftc-deceptive-advertising-charges-its-brain-training-program)

2.  Advocates for the Collective: the Essential Role of Clinical Advisory Boards - HealthTrust, accessed December 15, 2025, [[https://healthtrustpg.com/thesource/cqo/clinically-integrated-supply-chain/advocates-for-the-collective-the-essential-role-of-clinical-advisory-boards/]{.underline}](https://healthtrustpg.com/thesource/cqo/clinically-integrated-supply-chain/advocates-for-the-collective-the-essential-role-of-clinical-advisory-boards/)

3.  Altoida Expands Advisory Board with Global Leaders in AI, Pharma, and Alzheimer\'s Patient Advocacy to Accelerate the Advancement of its Category-Defining Digital Brain Health Platform \| Morningstar, accessed December 15, 2025, [[https://www.morningstar.com/news/business-wire/20251007367972/altoida-expands-advisory-board-with-global-leaders-in-ai-pharma-and-alzheimers-patient-advocacy-to-accelerate-the-advancement-of-its-category-defining-digital-brain-health-platform]{.underline}](https://www.morningstar.com/news/business-wire/20251007367972/altoida-expands-advisory-board-with-global-leaders-in-ai-pharma-and-alzheimers-patient-advocacy-to-accelerate-the-advancement-of-its-category-defining-digital-brain-health-platform)

4.  Environmental Press; A Case Study \| Aging In Place Resources, accessed December 15, 2025, [[https://aginginplace.com/environmental-press-a-case-study/]{.underline}](https://aginginplace.com/environmental-press-a-case-study/)

5.  Use of the physical environment to support everyday activities for people with dementia: A systematic review - PubMed Central, accessed December 15, 2025, [[https://pmc.ncbi.nlm.nih.gov/articles/PMC6039869/]{.underline}](https://pmc.ncbi.nlm.nih.gov/articles/PMC6039869/)

6.  Function-Focused Person-Environment Fit for Long-Term Care Residents With Dementia: Impact on Apathy - PubMed, accessed December 15, 2025, [[https://pubmed.ncbi.nlm.nih.gov/32833010/]{.underline}](https://pubmed.ncbi.nlm.nih.gov/32833010/)

7.  User Experience Design for Persons Living With Dementia - ThinkMind, accessed December 15, 2025, [[https://www.thinkmind.org/articles/etelemed_2020_3_230_40095.pdf]{.underline}](https://www.thinkmind.org/articles/etelemed_2020_3_230_40095.pdf)

8.  The Aftermath of Abandoned Neurotech: Ethical and Regulatory Challenges in the Dawn of Brain-Computer Interfaces - Knowing Neurons, accessed December 15, 2025, [[https://knowingneurons.com/abandoned_neurotech/]{.underline}](https://knowingneurons.com/abandoned_neurotech/)

9.  Occupational Therapist vs. Speech Pathologist \| Maryville Online, accessed December 15, 2025, [[https://slp.maryville.edu/blog/occupational-therapist-vs-speech-pathologist/]{.underline}](https://slp.maryville.edu/blog/occupational-therapist-vs-speech-pathologist/)

10. Occupational Therapy vs Speech-Language Pathology: Career Comparison Guide, accessed December 15, 2025, [[https://www.speechpathologygraduateprograms.org/occupational-therapy/]{.underline}](https://www.speechpathologygraduateprograms.org/occupational-therapy/)

11. Language-Based Strategies that Support Person-Centered Communication in Formal Home Care Interactions with Persons Living with Dementia - NIH, accessed December 15, 2025, [[https://pmc.ncbi.nlm.nih.gov/articles/PMC9996793/]{.underline}](https://pmc.ncbi.nlm.nih.gov/articles/PMC9996793/)

12. 8 Communication Tips for Clinicians Treating Patients with Dementia, accessed December 15, 2025, [[https://foxrehab.org/patients-dementia-communication-tips/]{.underline}](https://foxrehab.org/patients-dementia-communication-tips/)

13. The value of privacy for people with dementia - Frontiers, accessed December 15, 2025, [[https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1437813/full]{.underline}](https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1437813/full)

14. Privacy, Consent, and Care: Rethinking the Ethics of Dementia Technologies - IRE Journals, accessed December 15, 2025, [[https://www.irejournals.com/formatedpaper/1712534.pdf]{.underline}](https://www.irejournals.com/formatedpaper/1712534.pdf)

15. Usability and privacy concerns around tech designed for older adults - ASA Generations, accessed December 15, 2025, [[https://generations.asaging.org/tech-older-adults-usability-privacy/]{.underline}](https://generations.asaging.org/tech-older-adults-usability-privacy/)

16. Multiple Life Care Services Senior Living Facilities Impacted by Data Breach, accessed December 15, 2025, [[https://www.hipaajournal.com/life-care-services-senior-living-data-breach/]{.underline}](https://www.hipaajournal.com/life-care-services-senior-living-data-breach/)

17. Hallucinations and delusions \| Dementia Australia, accessed December 15, 2025, [[https://www.dementia.org.au/living-dementia/mood-and-behaviour-changes/hallucinations-and-delusions]{.underline}](https://www.dementia.org.au/living-dementia/mood-and-behaviour-changes/hallucinations-and-delusions)

18. Hidden Effects of Dementia: How the Brain Distorts Sights, Sounds, and Spaces, accessed December 15, 2025, [[https://www.7dayhomecare.com/hidden-effects-of-dementia-how-the-brain-distorts-sights-sounds-and-spaces]{.underline}](https://www.7dayhomecare.com/hidden-effects-of-dementia-how-the-brain-distorts-sights-sounds-and-spaces)

19. 24 Hour Summary of the Digital Health Advisory Committee - November 6, 2025 - FDA, accessed December 15, 2025, [[https://www.fda.gov/media/189618/download]{.underline}](https://www.fda.gov/media/189618/download)

20. FDA Committee Meets on Generative AI Digital Mental Health Devices \| Psychiatric Times, accessed December 15, 2025, [[https://www.psychiatrictimes.com/view/fda-committee-meets-on-generative-ai-digital-mental-health-devices]{.underline}](https://www.psychiatrictimes.com/view/fda-committee-meets-on-generative-ai-digital-mental-health-devices)

21. FDA Digital Health Advisory Committee, accessed December 15, 2025, [[https://www.fda.gov/medical-devices/digital-health-center-excellence/fda-digital-health-advisory-committee]{.underline}](https://www.fda.gov/medical-devices/digital-health-center-excellence/fda-digital-health-advisory-committee)

22. FDA Seeks Guidance from the Digital Health Advisory Committee on AI: Considerations for Innovators of Digital Mental Health Medical Devices and Wellness Products - Baker Hostetler, accessed December 15, 2025, [[https://www.bakerlaw.com/insights/fda-seeks-guidance-from-the-digital-health-advisory-committee-on-ai-considerations-for-innovators-of-digital-mental-health-medical-devices-and-wellness-products/]{.underline}](https://www.bakerlaw.com/insights/fda-seeks-guidance-from-the-digital-health-advisory-committee-on-ai-considerations-for-innovators-of-digital-mental-health-medical-devices-and-wellness-products/)

23. GUIDE (Guiding an Improved Dementia Experience) Model - CMS, accessed December 15, 2025, [[https://www.cms.gov/priorities/innovation/innovation-models/guide]{.underline}](https://www.cms.gov/priorities/innovation/innovation-models/guide)

24. Guiding an Improved Dementia Experience by Clearing the Path for Comprehensive, High-Quality Dementia Care \| CMS, accessed December 15, 2025, [[https://www.cms.gov/blog/guiding-improved-dementia-experience-clearing-path-comprehensive-high-quality-dementia-care]{.underline}](https://www.cms.gov/blog/guiding-improved-dementia-experience-clearing-path-comprehensive-high-quality-dementia-care)

25. Evaluation of the Program of All- Inclusive Care for the Elderly (PACE) Demonstration The Impact of PACE on Participant Outcomes - CMS, accessed December 15, 2025, [[https://www.cms.gov/files/document/paceoutcomespdf]{.underline}](https://www.cms.gov/files/document/paceoutcomespdf)

26. Program of All-Inclusive Care for the Elderly (PACE) versus Other Programs: A Scoping Review of Health Outcomes - NIH, accessed December 15, 2025, [[https://pmc.ncbi.nlm.nih.gov/articles/PMC8938794/]{.underline}](https://pmc.ncbi.nlm.nih.gov/articles/PMC8938794/)

27. Improving quality measurement for dementia care - PMC - PubMed Central, accessed December 15, 2025, [[https://pmc.ncbi.nlm.nih.gov/articles/PMC12000237/]{.underline}](https://pmc.ncbi.nlm.nih.gov/articles/PMC12000237/)

28. GUIDE Model Strength in Partnerships Fact Sheet - CMS, accessed December 15, 2025, [[https://www.cms.gov/files/document/guide-strength-partners-fs.pdf]{.underline}](https://www.cms.gov/files/document/guide-strength-partners-fs.pdf)

29. Role and Responsibilities of Geriatric Psychiatrists or Geropsychiatrists - Center for Elder Abuse Solutions, accessed December 15, 2025, [[https://elderabuse.weill.cornell.edu/sites/default/files/e-mdts-geriatric-psychiatrists-role-v5-final_0.pdf]{.underline}](https://elderabuse.weill.cornell.edu/sites/default/files/e-mdts-geriatric-psychiatrists-role-v5-final_0.pdf)

30. You have interrupted me again!: making voice assistants more dementia-friendly with incremental clarification - PubMed Central, accessed December 15, 2025, [[https://pmc.ncbi.nlm.nih.gov/articles/PMC11285561/]{.underline}](https://pmc.ncbi.nlm.nih.gov/articles/PMC11285561/)

31. Speech Pathology vs. Occupational Therapy: Which Career Is Right for You?, accessed December 15, 2025, [[https://www.alliant.edu/blog/speech-pathology-vs-occupational-therapy]{.underline}](https://www.alliant.edu/blog/speech-pathology-vs-occupational-therapy)

32. Communication Strategies in FTD - The Association for Frontotemporal Degeneration, accessed December 15, 2025, [[https://www.theaftd.org/wp-content/uploads/2018/01/January-2012.pdf]{.underline}](https://www.theaftd.org/wp-content/uploads/2018/01/January-2012.pdf)

33. Training Clinical Researchers with Design Thinking to To Develop Dementia Caregiving Research Initiatives - PMC - NIH, accessed December 15, 2025, [[https://pmc.ncbi.nlm.nih.gov/articles/PMC9578440/]{.underline}](https://pmc.ncbi.nlm.nih.gov/articles/PMC9578440/)

34. Co-designed technologies and people living with dementia: A qualitative systematic review, accessed December 15, 2025, [[https://www.tandfonline.com/doi/full/10.1080/10376178.2025.2500377]{.underline}](https://www.tandfonline.com/doi/full/10.1080/10376178.2025.2500377)

35. NIA Small Business Programs (SBIR & STTR) - National Institute on Aging - NIH, accessed December 15, 2025, [[https://www.nia.nih.gov/research/sbir]{.underline}](https://www.nia.nih.gov/research/sbir)

36. NIH small business funding boosts Alzheimer\'s science advances, accessed December 15, 2025, [[https://www.alzheimers.gov/news/nih-small-business-funding-boosts-alzheimers-science-advances]{.underline}](https://www.alzheimers.gov/news/nih-small-business-funding-boosts-alzheimers-science-advances)

37. Ex-Google accel Punto Health bags \$2.7M to build \'OS for dementia care\' with speech AI biomarkers - Tech Funding News, accessed December 15, 2025, [[https://techfundingnews.com/punto-health-2-7m-seed-ai-dementia-care-platform/]{.underline}](https://techfundingnews.com/punto-health-2-7m-seed-ai-dementia-care-platform/)

38. Effects of Family Audio Recordings on Depression, Cognitive Function, and Sleep Quality of Individuals With Alzheimer\'s Disease: A Randomized Controlled Trial - Slack Journals, accessed December 15, 2025, [[https://journals.healio.com/doi/10.3928/00989134-20241010-02]{.underline}](https://journals.healio.com/doi/10.3928/00989134-20241010-02)

39. Dementia: Specific Therapies - LA County Department of Mental Health, accessed December 15, 2025, [[https://dmh.lacounty.gov/for-providers/administrative-tools/dementia-therapies/]{.underline}](https://dmh.lacounty.gov/for-providers/administrative-tools/dementia-therapies/)

40. Senior Living Nonprofits See Staffing, Funding, Time Constraints as Top Barriers to Implementing Tech, accessed December 15, 2025, [[https://seniorhousingnews.com/2025/09/29/senior-living-nonprofits-see-staffing-funding-time-constraints-as-top-barriers-to-implementing-tech/]{.underline}](https://seniorhousingnews.com/2025/09/29/senior-living-nonprofits-see-staffing-funding-time-constraints-as-top-barriers-to-implementing-tech/)

41. Barriers to Implementing Technology in Residential Long-Term Care Settings \| ASPE, accessed December 15, 2025, [[https://aspe.hhs.gov/reports/barriers-implementing-technology-residential-long-term-care-settings-1]{.underline}](https://aspe.hhs.gov/reports/barriers-implementing-technology-residential-long-term-care-settings-1)

42. Memory Care Innovation Award Winner: Ryan Muzzey, Memory Care Director, Clarendale of St. Peters - Senior Housing News, accessed December 15, 2025, [[https://seniorhousingnews.com/2024/07/31/memory-care-innovation-award-winner-ryan-muzzey-memory-care-director-clarendale-of-st-peters/]{.underline}](https://seniorhousingnews.com/2024/07/31/memory-care-innovation-award-winner-ryan-muzzey-memory-care-director-clarendale-of-st-peters/)

43. Memory Care Innovation Award Winner: Elizabeth Thompson, Regional Director of Memory Care, Arrow Senior Living - Senior Housing News, accessed December 15, 2025, [[https://seniorhousingnews.com/2024/08/07/memory-care-innovation-award-winner-elizabeth-thompson-regional-director-of-memory-care-arrow-senior-living/]{.underline}](https://seniorhousingnews.com/2024/08/07/memory-care-innovation-award-winner-elizabeth-thompson-regional-director-of-memory-care-arrow-senior-living/)

44. Amicus Brain Innovations - Company Profile - AgeTech Collaborative from AARP, accessed December 15, 2025, [[https://home.agetechcollaborative.org/startup/network/findacompany/companyprofile?UserKey=18e28286-10f6-4220-8480-0184821eb509]{.underline}](https://home.agetechcollaborative.org/startup/network/findacompany/companyprofile?UserKey=18e28286-10f6-4220-8480-0184821eb509)

45. Find Companies - AgeTech Collaborative from AARP, accessed December 15, 2025, [[https://home.agetechcollaborative.org/network/company-directory]{.underline}](https://home.agetechcollaborative.org/network/company-directory)

46. GUIDE Model - Dementia Care Aware, accessed December 15, 2025, [[https://www.dementiacareaware.org/guidemodel/]{.underline}](https://www.dementiacareaware.org/guidemodel/)

47. NIA Small Business Research Areas \| National Institute on Aging - NIH, accessed December 15, 2025, [[https://www.nia.nih.gov/research/sbir/nia-small-business-research-areas]{.underline}](https://www.nia.nih.gov/research/sbir/nia-small-business-research-areas)

48. UCSD \| The Pa Lab, accessed December 15, 2025, [[https://www.palab.ucsd.edu/]{.underline}](https://www.palab.ucsd.edu/)

49. Alzheimer\'s Disease Research Centers: National Research Centers, Local Resources, accessed December 15, 2025, [[https://www.alzheimers.gov/taking-action/national-research-centers]{.underline}](https://www.alzheimers.gov/taking-action/national-research-centers)

50. Center for Alzheimer\'s Disease Research \| Carney Institute for Brain Science \| Brown University, accessed December 15, 2025, [[https://alz.carney.brown.edu/]{.underline}](https://alz.carney.brown.edu/)

51. NYU Langone\'s Alzheimer\'s Disease Research Center, accessed December 15, 2025, [[https://med.nyu.edu/centers-programs/alzheimers-disease-research/]{.underline}](https://med.nyu.edu/centers-programs/alzheimers-disease-research/)

52. Goizueta Alzheimer\'s Disease Research Center \| Emory University \| Atlanta GA, accessed December 15, 2025, [[https://alzheimers.emory.edu/]{.underline}](https://alzheimers.emory.edu/)

53. Guide Model Participant List - CMS, accessed December 15, 2025, [[https://www.cms.gov/priorities/innovation/files/guide-participant-list.xlsx]{.underline}](https://www.cms.gov/priorities/innovation/files/guide-participant-list.xlsx)

54. Digital Health Advisory Committee \| FDA, accessed December 15, 2025, [[https://www.fda.gov/advisory-committees/committees-and-meeting-materials/digital-health-advisory-committee]{.underline}](https://www.fda.gov/advisory-committees/committees-and-meeting-materials/digital-health-advisory-committee)

55. Sensi AI \| 24/7 Care Copilot for Home Care, accessed December 15, 2025, [[https://www.sensi.ai/]{.underline}](https://www.sensi.ai/)

56. Rethinking Consumer Health and Care: The Role of Digital Health in Neurodegenerative Diseases - 7wire Ventures, accessed December 15, 2025, [[https://www.7wireventures.com/perspectives/rethinking-consumer-health-and-care-the-role-of-digital-health-in-neurodegenerative-diseases/]{.underline}](https://www.7wireventures.com/perspectives/rethinking-consumer-health-and-care-the-role-of-digital-health-in-neurodegenerative-diseases/)

57. What Biotech Startups Pay Physicians in Advisory or Founding Roles - SalaryDr, accessed December 15, 2025, [[https://www.salarydr.com/blog/biotech-startup-physician-compensation]{.underline}](https://www.salarydr.com/blog/biotech-startup-physician-compensation)

58. Startup Advisor Agreement Template - HubSpot, accessed December 15, 2025, [[https://www.hubspot.com/startups/fundraising/startup-advisor-agreement-template]{.underline}](https://www.hubspot.com/startups/fundraising/startup-advisor-agreement-template)

59. Advisory board setup and compensation - WilmerHale Launch, accessed December 15, 2025, [[https://launch.wilmerhale.com/explore/formation/equity-incentives/advisory-board-setup-and-compensation]{.underline}](https://launch.wilmerhale.com/explore/formation/equity-incentives/advisory-board-setup-and-compensation)

60. Biotech Scientific Advisory Boards: What Works, What Doesn\'t - LifeSciVC, accessed December 15, 2025, [[https://lifescivc.com/2012/09/biotech-scientific-advisory-boards-what-works-what-doesnt/]{.underline}](https://lifescivc.com/2012/09/biotech-scientific-advisory-boards-what-works-what-doesnt/)

61. Free Patient Advisory Team Charter Template to Edit Online, accessed December 15, 2025, [[https://www.template.net/edit-online/359438/patient-advisory-team-charter]{.underline}](https://www.template.net/edit-online/359438/patient-advisory-team-charter)

62. Free Download Talent Advisory Board Charter Template - Meegle, accessed December 15, 2025, [[https://www.meegle.com/en_us/advanced-templates/online_recruitment/talent_advisory_board_charter_template]{.underline}](https://www.meegle.com/en_us/advanced-templates/online_recruitment/talent_advisory_board_charter_template)

63. advisor-agreement.docx, accessed December 15, 2025, [[https://www.wsgr.com/a/web/26508/advisor-agreement.docx]{.underline}](https://www.wsgr.com/a/web/26508/advisor-agreement.docx)

64. Advisor Agreement Templates & Models - Instant Downloads - Eloquens, accessed December 15, 2025, [[https://www.eloquens.com/category/legal/advisor-agreements/195]{.underline}](https://www.eloquens.com/category/legal/advisor-agreements/195)

65. Co-designing complex interventions with people living with dementia and their supporters, accessed December 15, 2025, [[https://pmc.ncbi.nlm.nih.gov/articles/PMC8811333/]{.underline}](https://pmc.ncbi.nlm.nih.gov/articles/PMC8811333/)

66. Co-design of a Smartphone App for People Living With Dementia by Applying Agile, Iterative Co-design Principles: Development and Usability Study - JMIR mHealth and uHealth, accessed December 15, 2025, [[https://mhealth.jmir.org/2022/1/e24483]{.underline}](https://mhealth.jmir.org/2022/1/e24483)

67. Barriers to and Facilitators of Digital Health Technology Adoption Among Older Adults With Chronic Diseases: Updated Systematic Review - PubMed Central, accessed December 15, 2025, [[https://pmc.ncbi.nlm.nih.gov/articles/PMC12464506/]{.underline}](https://pmc.ncbi.nlm.nih.gov/articles/PMC12464506/)

68. Patient-Related Barriers to Digital Technology Adoption in Alzheimer Disease: Systematic Review - PMC - NIH, accessed December 15, 2025, [[https://pmc.ncbi.nlm.nih.gov/articles/PMC12005595/]{.underline}](https://pmc.ncbi.nlm.nih.gov/articles/PMC12005595/)

69. (PDF) Ethical issues associated with assistive technologies for persons living with dementia and their caregivers - An overview of reviews - ResearchGate, accessed December 15, 2025, [[https://www.researchgate.net/publication/391777382_Ethical_issues_associated_with_assistive_technologies_for_persons_living_with_dementia_and_their_caregivers\_-\_An_overview_of_reviews]{.underline}](https://www.researchgate.net/publication/391777382_Ethical_issues_associated_with_assistive_technologies_for_persons_living_with_dementia_and_their_caregivers_-_An_overview_of_reviews)

70. FTC Issues Annual Report to Congress on Agency\'s Actions to Protect Older Adults, accessed December 15, 2025, [[https://www.ftc.gov/news-events/news/press-releases/2025/12/ftc-issues-annual-report-congress-agencys-actions-protect-older-adults]{.underline}](https://www.ftc.gov/news-events/news/press-releases/2025/12/ftc-issues-annual-report-congress-agencys-actions-protect-older-adults)
